A PILOT STUDY WITH ETHYL BIS (2,2-DIMETHYL-1-AZIRIDINYL) PHOSPHINATE (AB-163) AND RADIATION THERAPYBELGRAD R; WAMPLER GL.1982; INT. J. RADIAT. ONCOL., BIOL., PHYS.; ISSN 0360-3016; USA; DA. 1982; VOL. 8; NO 7; PP. 1219-1223; BIBL. 18 REF.Article

ANTILEUKEMIC EFFECT OF HOMO-AZA-STEROIDAL ESTER OF P-BIS(2-CHLOROETHYL) AMINO PHENYL ACETIC ACID.WAMPLER GL; CATSOULACOS P.1977; CANCER TREATM. REP.; U.S.A.; DA. 1977; VOL. 61; NO 1; PP. 37-41; BIBL. 21 REF.Article

ACTIVITY OF 3BETA -HYDROXY-13ALPHA -AMINO-13, 17-SECO-5ALPHA -ANDROSTANE-17-OIC-13, 17-LACTAM (P-(BIS(2-CHLOROETHYL) AMINO)-PHENYL) ACETATE (NSC 290 205) IN MURINE SOLID TUMORSCATSOULACOS P; WAMPLER GL.1982; ONCOLOGY; ISSN 0030-2414; CHE; DA. 1982; VOL. 39; NO 2; PP. 109-112; BIBL. 26 REF.Article

ANTILEUKEMIC EFFECTS OF THE HOMO-AZA-STEROIDAL ESTER OF (P-(BIS(2-CHLOROETHYL) AMINO) PHENYLTHIO) ACETIC ACIDCATSOULACOS P; WAMPLER GL.1979; EUROP. J. MEDICIN. CHEM.; FRA; DA. 1979; VOL. 14; NO 1; PP. 95-96; BIBL. 7 REF.Article

ABSENCE OF CROSS-RESISTANCE TO ALKYLATING AGENTS IN CYCLOPHOSPHAMIDE-RESISTANT L1210 LEUKEMIAWAMPLER GL; REGELSON W; BARDOS TJ et al.1978; EUROP. J. CANCER; GBR; DA. 1978; VOL. 14; NO 9; PP. 977-982; BIBL. 13 REF.Article

PHASE I STUDY OF ETHYLBIS (2,2-DIMETHYL-1-AZIRIDINYL) PHOSPHINATE (AB-163)WAMPLER GL; KUPERMINC M; REGELSON W et al.1980; CANCER CHEMOTHER. PHARMACOL.; DEU; DA. 1980; VOL. 4; NO 1; PP. 49-52; BIBL. 11 REF.Article

INTERSTITIAL PULMONARY FIBROSIS AS A COMPLICATION OF PROLONGED METHYL-CCNU THERAPYLEE W; MOORE RP; WAMPLER GL et al.1978; CANCER TREATM. REP.; USA; DA. 1978; VOL. 62; NO 9; PP. 1355-1358; BIBL. 2 REF.Article

NEW RIBONUCLEOTIDE REDUCTASE INHIBITORS WITH ANTINEOPLASTIC ACTIVITYELFORD HL; WAMPLER GL; VAN'T RIET B et al.1979; CANCER RES.; USA; DA. 1979; VOL. 39; NO 3; PP. 844-851; BIBL. 25 REF.Article

AN IMPROVED METHOD FOR ANALYZING SURVIVAL DATA FROM COMBINATION CHEMOTHERAPY EXPERIMENTSCARTER WH; STABLEIN DM; WAMPLER GL et al.1979; CANCER RES.; USA; DA. 1979; VOL. 39; NO 9; PP. 3446-3453; BIBL. 19 REF.Article

COMBINATION CHEMOTHERAPY: ARRIVING AT OPTIMAL TREATMENT LEVELS BY INCORPORATING SIDE EFFECT CONSTRAINTS.WAMPLER GL; CARTER WH JR; WILLIAMS VR et al.1978; CANCER TREATM. REP.; U.S.A.; DA. 1978; VOL. 62; NO 3; PP. 333-340; BIBL. 7 REF.Article

PHASE II STUDY OF VM-26 IN ADULT MALIGNANCIESSPREMULLI E; SCHULZ JJ; SPECKHART VJ et al.1980; CANCER TREATM. REP.; USA; DA. 1980; VOL. 64; NO 1; PP. 147-149; BIBL. 9 REF.Article

HEXAMETHYLMELAMINE (NSC-13875) IN THE TREATMENT OF ADVANCED CANCERWAMPLER GL; MELLETTE SJ; KUPERMINC M et al.1972; CANCER CHEMOTHERAPY REP., 1; U.S.A.; DA. 1972; VOL. 56; NO 4; PP. 505-514; BIBL. 4REF.Serial Issue

DRUG ACTIVITY AND THERAPEUTIC SYNERGISM IN CANCER TREATMENTCARTER WH JR; WAMPLER GL; STABLEIN DM et al.1982; CANCER RESEARCH; ISSN 0008-5472; USA; DA. 1982; VOL. 42; NO 8; PP. 2963-2971; BIBL. 15 REF.Article

ANTITUMOR ACTIVITY OF TETRAACETYGLUCOSAMINE MUSTARD.WAMPLER GL; NASSIRI SK; HSIAO YY et al.1975; CANCER RES.; U.S.A.; DA. 1975; VOL. 35; NO 8; PP. 1903-1906; BIBL. 11 REF.Article

ON DETERMINING THE LEVELS OF TREATMENT TO OPTIMIZE THE PROBABILITY OF A FAVORABLE RESPONSE.CARTER WH JR; WAMPLER GL; CREWS SL et al.1977; CANCER TREATM. REP.; U.S.A.; DA. 1977; VOL. 61; NO 5; PP. 849-853; BIBL. 12 REF.Article

EFFECT TO TILORONE HYDROCHLORIDE AND CONGENERS ON RETICULOENDOTHELIAL SYSTEM, TUMORS, AND THE IMMUNE RESPONSE = EFFET DU CHLORHYDRATE DE TILORONE ET DE COMPOSES APPARENTES SUR LE SYSTEME RETICULO-ENDOTHELIAL, LES TUMEURS ET LA REPONSE IMMUNEMUNSON AE; MUNSON JA; REGELSON W et al.1972; CANCER RES.; U.S.A.; DA. 1972; VOL. 32; NO 7; PP. 1397-1403; BIBL. 18REF.Serial Issue